Harnessing mesenchymal stem cell homing as an anticancer therapy

Area of Science:

• Oncology
• Cell Therapy
• Gene Therapy

Background:

• Mesenchymal stromal cells (MSCs) are non-hematopoietic progenitor cells utilized in cell-based cancer therapies.
• MSCs possess an innate ability to infiltrate malignant tissues, making them suitable delivery vehicles.
• Engineered MSCs have demonstrated efficacy in preclinical solid tumor models.

Purpose of the Study:

• To review current advancements in MSC-based gene therapy for tumor treatment.
• To explore diverse strategies for MSC-targeted tumor therapy.
• To discuss challenges and future prospects for clinical applications.

Main Methods:

• Review of current literature on MSC-based gene therapy.
• Analysis of engineering approaches for MSCs.
• Evaluation of MSC tumor tropism mechanisms.

Main Results:

• MSC-based gene therapy has advanced to early clinical trials for solid tumors.
• Various engineering strategies have shown efficacy in preclinical settings.
• Significant progress has been made in understanding MSC tumor homing.

Conclusions:

• MSC-based gene therapy is a developing field with potential for solid tumor treatment.
• Further research is required to address mechanisms of tumor tropism and optimal cell sourcing.
• Identifying suitable transgenes and target tumor types is crucial for clinical success.